Almost a year after two historic approvals, Pfizer is pulling a sickle cell disease treatment from the market, and the ...

Agios Pharmaceuticals (NASDAQ:AGIO) is scheduled to announce Q3 earnings results on Thursday, October 31st, before market open. The consensus EPS Estimate is $7.91 and the consensus Revenue Estimate ...

Pfizer Inc. Chief Executive Officer Albert Bourla said he’ll do “whatever it takes” to keep profits growing, including ...

Pfizer Inc (PFE) reports a 32% operational revenue growth and raises full-year guidance, despite challenges in COVID-19 ...